Is the patient’s baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?

by Michel Aubier, John Haughney, Olof Selroos, Onno C. P. van Schayck, Tommy Ekström, Juliette Ostinelli, Roland Buhl
Published 2011-10-01